USP Helps Expand Worldwide Access to Tuberculosis Drugs - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Helps Expand Worldwide Access to Tuberculosis Drugs



The US Pharmacopeial Convention (USP) and the US Agency for International Development (USAID) through the Promoting the Quality of Medicines (PQM) program has funded Capreomycin, the first “second line” anti-tuberculosis API for injectables. Capreomycin has been assessed by the World Health Organization (WHO) and given prequalification status.

Since 2009, USAID and USP, through the PQM program, have been providing technical and professional assistance to manufacturers and regulatory agencies in countries around the world to strengthen quality assurance systems for medicines, guide manufacturers toward compliance with WHO good manufacturing practices, and help manufacturers prepare product dossiers for submission to the WHO prequalification program.

As a result, the PQM program has helped three drugs achieve prequalification status including: Cycloserine, an anti-tuberculosis medicine; ZinCfant, a zinc product for managing diarrhea in children; and Capreomycin.

Source: USP

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here